Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) is preparing to deliver 12, 000 antibody treatment to the Czech Republic before the authorization of the EU. The Czech Republic is experiencing a strong wave of coronavirus which forced the state to order the doses before the approval of authorities.
The combination of casirivimab and imdevimab will soon get approval from the Czech Republic. The combination of both has got the emergency use permission in the US in November. It was also injected into the then US President Donald Trump when he got COVID-19 at that time.
PM Babis has disclosed that the state has ordered 12,000 antibody drugs. Out of 12,000, 4000 will be delivered in March, 4,000 in April, and the same in May. The antibody-drug will be given to the sufferers who are experiencing mild to moderate infection and have the risk of the worsening condition in the future.
Earlier, Czech Republic has provided the EUA to the treatment of Eli Lilly and has also ordered 500 doses earlier. In the Czech Republic, nearly 19K people have lost their lives and in the past few days, nearly 10k people have got the infection.
The country has controlled 538,448 vaccines. The data of the Health Ministry disclosed that nearly 204,795 people have received both doses as of Friday. On February 4, EMA commented that it is assessing the data of both the treatment for use in some sufferers.